Thursday, November 21
Symposium 19:05～11:05 Room1
S1-3 Current status of clinical immuno-radiotherapy research
| Speaker: | Dirk De Ruysscher （Maastricht University Medical Center, Department of Radiation Oncology (Maastro Clinic), GROW School for Oncology and Developmental Biology, Maastricht, The Netherlands） |
|---|
Friday, November 22
Japan-China-Korea trilateral symposium 19:10～10:00 Room4
Brachytherapy for head & neck cancer
| Chair: | Yasushi Nagata （Department of Radiation Oncology, Hiroshima University） |
|---|
TS1-1 Ruthenium-106 Brachytherapy with or without Additional Local Therapy Shows Favorable Outcome for Variable-Sized Choroidal Melanomas in Korean Patients
| Speaker: | Yeon Ah Jo （Department of Radiation Oncology Gangnam Severance Hospital, Yonsei University College of Medicine） |
|---|
TS1-2 3D-printing Technology and Low Dose Rate Ablation Brachytherapy for recurrent head and neck carcinoma
| Speaker: | Junjie Wang （Department of Radiation Oncology .Peking University 3rd Hospital, Beijing, China） |
|---|
TS1-3 Current status of brachytherapy for head and neck cancer
| Speaker: | Ryoichi Yoshimura （Department of Radiation Therapeutics and Oncology, Tokyo Medical and Dental University） |
|---|
Japan-China-Korea trilateral symposium 210:00～10:50 Room4
Liver cancer
| Chair: | Jaeho Cho （Department of Radiation Oncology, Yonsei University Medical College） |
|---|
TS2-1 Image-guided IMRT improves survival for unresectable HCC---experience from Zhongshan Hospital
| Speaker: | Zhao-Chong Zeng （Department of Radiation Oncology, Zhongshan hospital, Fudan University, Shanghai.） |
|---|
TS2-2 The Role of Radiation Therapy for Hepatocellular Carcinoma in Japan
| Speaker: | Naoko Sanuki （Department of Radiation Oncology, Mie Prefectural General Mediacal Center / Ofuna Chuo Hosp.） |
|---|
TS2-3 2018 KLCA-NCC Korea Guidelines for the Management of Hepatocellular Carcinoma:Focus on Radiotherapy
| Speaker: | Hee Chul Park （Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University） |
|---|
Japan-China-Korea trilateral symposium 310:50～11:40 Room4
Esophageal cancer
| Chair: | Jun Ma （Department of Radiation Oncology, Sun Yat-sen University Cancer Center (SYSUCC)） |
|---|
TS3-1 Radiation Therapy for Esophageal Cancer in Japan
| Speaker: | Keiichi Jingu （Department of Radiation Oncology, Tohoku University Graduate School of Medicine） |
|---|
TS3-2 Current Status of Radiotherapy for Esophageal Cancer in Korea
| Speaker: | Jong Hoon Kim （Department of Radiation Oncology, Asan Medical Center University of Ulsan College of Medicine） |
|---|
TS3-3 What have been done about radiotherapy for esophageal squamous cell cancer in China
| Speaker: | Xueying Qiao （Department of Radiation Oncology, Hebei Medical University Fourth Hospital） |
|---|
International Session13:25～14:55 Room6
| Chairs: | Tomoaki Tamaki （Fukushima Medical University） Naoko Sanuki （Mie Prefectural General Medical Center） |
|---|
IS-1 Is Definitive Treatment for Oligometastatic Disease the New Standard of Care? Current State of the Field.
| Speaker: | Chad Tang （Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston TX） |
|---|
IS-2 Radiation Vaccination. Evidence for Radiation Treatment in Low Volume Disease.
| Speaker: | Hany Elsaleh （Radiation Oncology, The Alfred Hospital and Monash University, Melbourne, Australia） |
|---|
IS-3 Evaluation of deformable image registration accuracy for brachytherapy using two different commercial software in cervical cancer
| Speaker: | Siwaporn Sakulsingharoj （Department of Radiation Oncology, Tohoku University School of Medicine, Japan / Department of Diagnostic and Therapeutic Radiology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Thailand） |
|---|
IS-4 Assessment of the intra-fractional tumor motion during stereotactic body radiotherapy (SBRT) period in patients with stage I non-small cell lung cancer: Could the tumor changes in location over an SBRT course relate to the prognosis?
| Speaker: | Nam Vu Hong （Department of Radiology, University of Yamanashi, Yamanashi, Japan） |
|---|
IS-5 A hypoxia-inducible secretory protein (HISP2) causes cancer radioresistance in an autocrine manner
| Speaker: | Tatsuya Suwa （Lab of Cancer Cell Biology, Graduate School of Biostudies, Kyoto University） |
|---|
IS-6 Efficacy of radiation for focally tumor-exposed margin after breast conserving surgery: an update
| Speaker: | Ryoko Suzuki （Department of Radiation Oncology, Cancer Institute Hospital） |
|---|
